Glaukos (GKOS) Operating Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 3,146.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,146.00 |
| Dec 31, 2025 | 6,077.00 |
| Sep 30, 2025 | 1,807.00 |
| Jun 30, 2025 | 3,229.00 |
| Mar 31, 2025 | -3,385.00 |
| Dec 31, 2024 | 8,423.00 |
| Sep 30, 2024 | -4,027.00 |
| Jun 30, 2024 | -1,311.00 |
| Mar 31, 2024 | -2,826.00 |
| Dec 31, 2023 | -3,134.00 |
| Sep 30, 2023 | -1,684.00 |
| Jun 30, 2023 | 11,339.00 |
| Mar 31, 2023 | 5,043.00 |
| Dec 31, 2022 | -226.00 |
| Sep 30, 2022 | -910.00 |
| Jun 30, 2022 | -3,993.00 |
| Mar 31, 2022 | 1,806.00 |
| Dec 31, 2021 | -2,791.00 |
| Sep 30, 2021 | 3,055.00 |
| Jun 30, 2021 | -837.00 |
| Mar 31, 2021 | -811.00 |
| Dec 31, 2020 | -1,683.00 |
| Sep 30, 2020 | -2,090.00 |
| Jun 30, 2020 | -14,019.00 |
| Mar 31, 2020 | -9,592.00 |
| Dec 31, 2019 | -4,651.00 |
| Sep 30, 2019 | -2,470.00 |
| Jun 30, 2019 | -1,808.00 |
| Mar 31, 2019 | -628.00 |
| Dec 31, 2018 | 1,340.00 |
| Sep 30, 2018 | -672.00 |
| Jun 30, 2018 | 2,047.00 |
| Mar 31, 2018 | -118.00 |
| Dec 31, 2017 | 3,684.00 |
| Sep 30, 2017 | 1,737.00 |
| Jun 30, 2017 | 1,086.00 |
| Mar 31, 2017 | 4,965.00 |